Serotonin-producing enterochromaffin cell tumors of the pancreas: Clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors

Pancreas

Volumn 40, Issue 6, 2011, Pages 883-895

  La Rosa, Stefano ^a   Franzi, Francesca ^b   Albarello, Luca ^c   Schmitt, Anja ^d   Bernasconi, Barbara ^b   Tibiletti, Maria Grazia ^a   Finzi, Giovanna ^a   Placidi, Claudia ^b   Perren, Aurel ^d   Capella, Carlo ^a,b  

^a OSPEDALE DI CIRCOLO   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

carcinoid; EC cell; endocrine tumor; pancreas; serotonin

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ACIDIC FIBROBLAST GROWTH FACTOR; CALCITONIN; CHROMOGRANIN A; CHROMOGRANIN B; CONNECTIVE TISSUE GROWTH FACTOR; DIAZONIUM COMPOUND; GASTRIN; GLUCAGON; INSULIN; PANCREAS POLYPEPTIDE; PROTEIN S 100; SEROTONIN; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 2A; SUBSTANCE P; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORPHOLOGY; CANCER SURVIVAL; CARCINOID SYNDROME; CELL INVASION; CELL ULTRASTRUCTURE; CHROMOSOME 18; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CYTOGENETICS; ENTEROCHROMAFFIN CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE SEROTONIN PRODUCING ENTEROCHROMAFFIN CELL TUMOR; INTESTINE TUMOR; LYMPH NODE METASTASIS; MALE; MITOSIS; MONOSOMY; NECROSIS; PANCREAS SEROTONIN PRODUCING ENTEROCHROMAFFIN CELL TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; STROMA; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; CARCINOID TUMOR; CHROMOSOMES, HUMAN, PAIR 18; ENTEROCHROMAFFIN CELLS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; MALE; MALIGNANT CARCINOID SYNDROME; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; PANCREATIC NEOPLASMS; SEROTONIN;

EID: 80051550986     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31822041a9     Document Type: Article

References (77)

1. Oberndorfer S. Karzinoid tumoren des dünndarms. Frankfurt Z Pathol. 1907;1:426-429.
2. Solcia E, Klöppel G, Sobin LH, et al. Histological typing of endocrine tumours. WHO International Histological Classification of Tumours. 2nd ed. Berlin: Springer; 2000.
3. DeLellis RA. The neuroendocrine system and its tumors: An overview. Am J Clin Pathol. 2001;115(suppl):S5YS16.
4. Chetty R. Requiem for the term "carcinoid tumour" in the gastrointestinal tract? Can J Gastroenterol. 2008;22:357Y358.
5. Osamura RY, Oberg K, Speel EJM, et al. Serotonin-secreting tumours. In: DeLellis RA, Lloyd RV, Heitz PU, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004:198.
6. Peart WS, Porter KA. Carcinoid syndrome due to pancreatic-duct neoplasm secreting 5-hydroxytryotophan and 5-hydroxytryptamine. Lancet. 1963;1:239-243.
7. Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: Clarifying these clinical conundrums. World J Surg. 2005;29:92-101. (Pubitemid 40576497)
8. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-959. (Pubitemid 36173145)
9. Soga J. Carcinoids of the pancreas. An analysis of 156 cases. Cancer. 2005;104:1180-1187. (Pubitemid 41278952)
10. DeLellis RA, Lloyd RV, Heitz PU, et al. World Health Organization classification of tumours. Pathology & Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
11. Rindi G, Klöppel, G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch. 2006;449:395-401. (Pubitemid 44451313)
12. La Rosa S, Chiaravalli AM, Capella C, et al. Immunohistochemical localization of acidic fibroblast growth factor in normal human enterochromaffin cells and related gastrointestinal tumours. Virchows Arch. 1997;430:117Y124.
13. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem. 1981;25:577Y580.
14. Löllgen RM, Hessman O, Szabo E, et al. Chromosome 18 deletions are common events in classical midgut carcinoid tumors. Int J Cancer. 2001;92:812-815. (Pubitemid 32467369)
15. Kytola S, Hoog A, Norc B, et al. Comparative genomic hybridization identifies loss of 18q22-qte as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol. 2001;158: 1803-1808. (Pubitemid 32422945)
16. Tibiletti MG. Specificity of interphase fluorescence in situ hybridization for detection of chromosome aberrations in tumor pathology. Cancer Genet Cytogenet. 2004;155:143-148. (Pubitemid 39574924)
17. Soga J, Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer. 1971;28:990-998.
18. Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: A proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol. 2007;20:1172-1182. (Pubitemid 47609066)
19. Capella C, Finzi G, Cornaggia M, et al. Ultrastructural typing of gastric endocrine cells. In: Håkanson R, Sundler F, eds. The Stomach as an Endocrine Organ. Amsterdam: Elsevier; 1991:27Y52.
20. Solcia E, Capella C, Buffa R, et al. Endocrine cells of the digestive system. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York: Raven Press; 1981:39-58.
21. Capella C, Heitz PU, Höfler H, et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425:547Y560.
22. Gloor VF, Pletscher A, Hardmeier Th. Metastasierendes inselzelladenom des pancreas mit 5-hydroxytryptamin und insulinproduktion. Schwaiz Med Wonchenschr. 1965;94:1476-1480.
23. Persaud V, Walrond ER, Jamaica K. Carcinoid tumor and cystadenoma of the pancreas. Arch Path. 1971;92:28-30.
24. Patchefsky AS, Gordon G, Harrer W, et al. Carcinoid tumor of the pancreas. Ultrastructural observations of a lymph node metastasis and comparison with bronchial carcinoid. Cancer. 1974;33:1349-1354.
25. Wilander E, El-Salhy M, Willen R, et al. Immunocytochemistry and electron microscopy of an argentaffin endocrine tumour of the pancreas. Virchows Arch A. 1981;392:263-269. (Pubitemid 11039286)
26. Prinz RA, Bermes EW, Chejfec G, et al. A serotonin and AHCG-producing islet cell carcinoma associated with focal nodular hyperplasia of the liver. J Surg Oncol. 1983;24:30-32. (Pubitemid 13004146)
27. Carstens PHB, Cressman FK. Malignant oncocytic carcinoid of the pancreas. Ultrastruct Pathol. 1989;13:69-75. (Pubitemid 19054613)
28. Kanavaros P, Hoang C, Le Bodic MF, et al. Serotonin-producing pancreatic endocrine tumour. Histological, ultrastructural and immunohistochemical study of a case. Histol Histopathol. 1990;5: 325-328. (Pubitemid 20305489)
29. Wilson RW, Gal AA, Cohen C, et al. Serotonin immunoreactivity in pancreatic endocrine neoplasms (carcinoid tumors). Mod Pathol. 1987;4:727Y732.
30. Nagai E, Yamaguchi K, Hashimoto H, et al. Carcinoid tumor of the pancreas with obstructive pancreatitis. Am J Gastroenterol. 1992;87: 361-364.
31. Taidi C, Soyer P, Barge J, et al. Tumeur carcinoide primitive du pancréas. Aspect tomodensitométriques et écho- endoscopiques. J Radiol. 1993;74:437Y350.
32. Villanueva A, Pérez C, Llauger J, et al. Carcinoid tumors of the pancreas: CT findings. Abdom Imaging. 1994;19:221-224. (Pubitemid 24126419)
33. Mao C, El Attar A, Domenico DR, et al. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature. Int J Pancreatol. 1998;23:153-164. (Pubitemid 28272199)
34. Hiller N, Berlowitz D, Fisher D, et al. Primary carcinoid tumor of the pancreas. Abdom Imaging. 1998;23:188-190. (Pubitemid 28157696)
35. Gunji N, Miyamoto H, Orii K, et al. Pancreatic carcinoid: Transcatheter arterial chemoembolization of liver metastases. Hepatogastroenterology. 2003;50:2166-2168. (Pubitemid 37468017)
36. Saint-Marc O, Cogliandolo A, Pozzo A, et al. A primary pancreatic carcinoid tumour with unusual clinical complaints: A case report. World J Surg Oncol. 2004;2:3.
37. Kim HC, Park SI, Park SJ, et al. Pancreatic carcinoid tumor with obstructive pancreatitis: Multislice helical CT appearance. Abdom Imaging. 2005;30:601-604. (Pubitemid 41446678)
38. Outtas O, Barthet M, De Troyer J, et al. Panniculite nodulaire et tumeur carcinoide intracanalaire d'un pancreas divisum. Ann Dermatol Venereol. 2004;131:466-469. (Pubitemid 38796813)
39. Bamba T, Kosugi SI, Kanda T, et al. Multiple carcinoids in the duodenum, pancreas and stomach accompanied with type A gastritis: A case report. World J Gastroenterol. 2007;13:2247Y2249.
40. Hamada Y, Nakayama Y, Maeshiro K, et al. Two cases of primary carcinoid tumor of the pancreas associated with marked stenosis of the main pancreatic duct. Pancreas. 2009;38:834-835.
41. van Der Sluys Veer J, Choufoer JC, Querido A, et al. Metastasising islet-cell tumour of the pancreas associated with hypoglycaemia and carcinoid syndrome. Lancet. 1964;1:1416-1419.
42. Dollinger MR, Ratner LH, Shamoian CA, et al. Carcinoid syndrome associated with pancreatic tumors. Arch Intern Med. 1967;120: 575-580.
43. Gordon DL, Chang M, Schwartz MA. Carcinoid of the pancreas. Am J Med. 1970;51:412-415.
44. Appleyard TN, Losowsky MS. A pancreatic tumour with carcinoid syndrome and hypoglycaemia. Postgrad Med J. 1970;46: 159-162.
45. Greene JF, Doyle WF. Pancreatic islet cell carcinoid: A highly malignant form of carcinoid tumor. J Surg Oncol. 1974;6: 183-190.
46. Pedinielli L, Quilichini R, Futsch D, et al. double composante endocrine et esocrine avec sindrome carcinoide. A propos de deux observations. Chirugie. 1975;101:42-51.
47. King MD, Young DG, Hann IM, et al. Carcinoid syndrome: An unusual cause of diarrhoea. Arch Dis Child. 1985;60:269-271. (Pubitemid 15113041)
48. Ordonez NG, Manning JT, Raymond K. Argentaffin endocrine carcinoma (carcinoid) of the pancreas with concomitant breast metastasis: An immunohistochemical and electron microscopic study. Human Pathol. 1985;16:746-751. (Pubitemid 15070251)
49. Lee CH, Ching KN, Lui WY, et al. Carcinoid tumor of the pancreas causing the diarrheogenic syndrome: Report of a case combine with multiple endocrine neoplasia, type I. Surgery. 1986;99:123-129.
50. Khorsand J, Katz RL, Savaraj N. Malignant carcinoid of the pancreas: A cytologic, ultrastructural, and immunocytochemical study of a case diagnosed by fine-needle aspiration of a supraclavicular node metastasis. Diagn Cytopathol. 1987;3:222-227.
51. Deixonne B, Duchene D, Eledjam JJ, et al. Carcinome endocrine pancréatique à cellules EC (carcinoide) responsable d'une diarrhée chronique. J Chir. 1991;128:415-418.
52. Haq AU, Yook CR, Hiremath V, et al. Carcinoid syndrome in the absence of liver metastasis: A case report and review of the literature. Med Pediatr Oncol. 1992;20:221-223.
53. Maurer CA, Glaser C, Reubi JC, et al. Carcinoid of the pancreas. Digestion. 1997;58:410-414. (Pubitemid 27368084)
54. Migliori M, Tomassetti P, Lalli S, et al. Carcinoid of the pancreas. Pancreatology. 2002;2:163-166. (Pubitemid 34639092)
55. Billimoria KY, Tomlinson JS, Merkow RP, et al. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients. J Gastrointest Surg. 2007;11: 1460-1469.
56. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinico-pathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2009;40:30-40.
57. La Rosa S, Furlan D, Sessa F, et al. The endocrine pancreas. In: Lloyd RV, ed. Endocrine Pathology. Differential Diagnosis and Molecular Advances. 2nd ed. New York: Springer; 2010:367Y413.
58. Solcia E, Capella C, Fiocca R, et al. Disorders of the endocrine system. In: Ming S, Goldman H, eds. Pathology of the Gastrointestinal Tract. 2nd ed. Baltimore, MD: Williams & Wilkins; 1998:295-322.
59. Klöppel G, Rindi G, Anlauf M, et al. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 2007;451(suppl 1):S9YS27.
60. La Rosa S, Rigoli E, Uccella S, et al. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch. 2004;445:248-254. (Pubitemid 39286892)
61. Srivastava A, Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol. 2009;33:626-632.
62. La Rosa S, Uccella S, Capella C, et al. Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors: An immunohistochemical study. Appl Immunohistochem. 1998;6:199-208. (Pubitemid 28545924)
63. Kidd M, Modlin IM, Shapiro MD, et al. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol. 2007;13: 5208-5216. (Pubitemid 47527737)
64. Sobin LH, Hjermstad BM, Sesterhenn IA, et al. Prostatic acid phosphatase activity in carcinoid tumors. Cancer. 1986;58:136-138. (Pubitemid 16093116)
65. Azumi N, Trawwek T, Battifora H. Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies. Am J Surg Pathol. 1991;15:785-790.
66. Rindi G, Paolotti D, Fiocca R, et al. Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch. 2000;436:217Y223.
67. Modlin IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: An association with no explanation. Am J Gastroenterol. 2004;99: 2466-2478. (Pubitemid 40039380)
68. Beauchamp RD, Coffey RJ, Lyons RH, et al. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth. Cancer Res. 1991;51:5253-5260.
69. Chaudhry A, Papanicolau V, Öberg K, et al. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. Cancer Res. 1992;52:1006-1012.
70. Bordi C, Falchetti A, Buffa R, et al. Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cell of origin. Hum Pathol. 1994;25:175-180. (Pubitemid 24079639)
71. La Rosa S, Uccella S, Erba S, et al. Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system. Appl Immunohistochem Mol Morphol. 2001;9:319-328. (Pubitemid 33098141)
72. Shi C, Siegelman SS, Kawamoto S, et al. Dramatic pancreatic duct strictures secondary to small endocrine neoplasms: A manifestation of serotonin production? Lab Invest. 2010;90(suppl 1):371A.
73. Hessman O, Lindberg D, Einarsson A, et al. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN I-associated pancreatic endocrine tumors. Genes Chromosomes Cancer. 1999;26:258-264. (Pubitemid 29468347)
74. Leotlela PD, Jauch A, Holtgreve-Grez H, et al. Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer. 2003;10:437Y450.
75. Furlan D, Cerutti R, Uccella S, et al. Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res. 2004;10:947Y957.
76. Furlan D, Bernasconi B, Uccella S, et al. Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites. Clin Cancer Res. 2005;11:1765-1775. (Pubitemid 40471838)
77. Kim DH, Nagano Y, Choi IS, et al. Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genomic-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors. Genes Chromosomes Cancer. 2008;47:84-92. (Pubitemid 350191467)